Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Double Blind Randomized Placebo Controlled Trial Using 20% Intra-Oral Ketoprofen Gel for Migraine Prevention.

NCT01211795 is registered in ClinicalTrials.gov with Behar, Caren, M.D. as lead sponsor.

NCT NCT01211795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01211795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Double Blind Randomized Placebo Controlled Trial Using 20% Intra-Oral Ketoprofen Gel for Migraine Prevention.
Lead sponsor
Behar, Caren, M.D.
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2009
Completion date
June 30, 2011
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine